#USA #New York #Class Action #Pomerantz LLP #Reckitt Benckiser

Class Action Lawsuit Against Reckitt Benckiser

The Pomerantz Law Firm has announced a significant development for investors in Reckitt Benckiser Group Plc (OTCMKTS: RBGLY). A class action lawsuit has been initiated, which seeks to hold Reckitt Benckiser accountable for alleged securities fraud and unlawful business practices. Investors who suffered losses during a specific period are encouraged to come forward and potentially take on the role of lead plaintiff in the case.

The Class Action Details

To qualify for lead plaintiff status, individuals who expressed interest should reach out to Danielle Peyton at the Pomerantz Law Firm by August 4, 2025. Initial inquiries can be made via email or by phone, and those contacting via email are asked to provide their mailing address, phone number, and the number of shares they acquired in Reckitt's market participation. Interested parties can visit pomerantzlaw.com to view the full class action complaint and acquire additional information.

The lawsuit highlights a series of troubling allegations against Reckitt and some of its executives. It suggests that the Company may have engaged in practices detrimental to its shareholders, leading to a significant loss in shareholder value.

Recent Legal Precedents

This movement towards legal action comes on the heels of troubling verdicts against Reckitt's subsidiary, Mead Johnson. In a separate case, a jury found Mead Johnson liable for negligence due to insufficient warnings regarding its cow's milk-based infant formula, which was shown to increase the risk of necrotizing enterocolitis (NEC) in preterm infants. On March 15, 2024, a jury ruled against Mead Johnson, awarding $60 million in damages, causing Reckitt’s American Depositary Share (ADS) price to plummet by nearly 14%, closing at $11.44 per share.

Furthermore, this downward trend was exacerbated when a July 29, 2024 verdict against Abbott Laboratories awarded $495 million for similar allegations concerning their specialized baby formula. This verdict prompted Reckitt's ADS to drop another 9% to $10.64.

About Pomerantz LLP

Pomerantz LLP is recognized as a leading firm specializing in corporate and securities class action litigation. With a legacy stretching over 85 years, the firm has successfully advocated for victims of corporate misconduct and securities fraud, recovering extensive damages for class members. Founded by Abraham L. Pomerantz, often referred to as the 'dean of the class action bar', the firm has continuously fought for justice in corporate governance and securities law.

Investors feeling affected by Reckitt's alleged practices have an opportunity to stand against wrongful corporate actions and can seek further information to join the class action.

This class action serves as a crucial reminder for investors to remain vigilant about the practices of the companies in which they invest and understand their rights in cases of potential corporate fraud and liability. For more information on joining the class action, please reach out to the designated contacts - it might be your chance to make a difference in corporate accountability.

Contact Details:

• - Danielle Peyton
• - Pomerantz LLP
• - Email: [email protected]
• - Phone: 646-581-9980 ext. 7980